Cited by 64Telemedicine and Telehealth ImplementationDiabetes Management and ResearchDiabetes Management and Education

The Efficiency of Telemedicine to Optimize Metabolic Control in Patients with Type 1 Diabetes Mellitus: Telemed Study

Open access
Esmatjes, Enric, Jansà, Margarida, Roca, Daria, Pérez-Ferre, Natalia, del Valle, Laura, Martínez-Hervás, Sergio, Ruiz de Adana, Marisol, Linares, Francisca +5 more·2014·Diabetes Technology & Therapeutics

Abstract

Objective: This study evaluated the impact of an Internet-based telematic system on the economic and clinical management of patients with type 1 diabetes mellitus. Research Design and Methods: This 6-month prospective, randomized, comparative, open, multicenter study included patients with type 1 diabetes >18 years old treated with multiple insulin doses and with a glycated hemoglobin (HbA 1c ) level of >8%. We compared an intervention group (IG) (two face-to-face and five telematic appointments) with a control group (CG) (seven face-to-face appointments). The variables studied were (1) patient and healthcare team costs, (2) metabolic control, (3) knowledge of diabetes, (4) quality of life, and (5) self-care treatment adherence. Results: Of the 154 patients included, 118 (76.6%) completed the study (IG, 54; CG, 64). The time used by the CG to follow the program was 823±645 min versus 353±222 min in the IG ( P <0.0001). Compared with the CG, the IG required less healthcare time from the professionals (288±105 min vs. 232±89 min; P <0.001). HbA 1c improved in both groups (IG, 9.2±1.5% [77.0±17.0 mmol/mol] vs. 8.7±1.5% [71.6±17.0 mmol/mol] [ P <0.001]; CG, 9.2±0.9% [77.0±10.0 mmol/mol] vs. 8.6±0.9% [70.5±10.0 mmol/mol] [ P <0.001], as did knowledge and self-care treatment adherence. Conclusions: The use of interactive telematic appointments in subjects with type 1 diabetes and inadequate metabolic control is an efficient strategy, providing results comparable to those of face-to-face appointments in relation to improvement in glycemic control, knowledge acquisition, and self-care treatment adherence, with a significant reduction in the time used, especially by patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2013.0313

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Previous research suggests that components of virtual care interventions lead to positive outcomes for people with type 2 diabetes such as improved blood glucose control and knowledge to manage their diabetes.

    “Previous research suggests that components of virtual care interventions lead to positive outcomes for people with type 2 diabetes such as improved blood glucose control and knowledge to manage their diabetes [9, 10].”

    From Effect of virtual care in type 2 diabetes management – a systematic umbrella review of systematic reviews and meta-analysis (2025) · cites this paper as [9]

    The Clinical evolution section (page not provided) reports improved HbA1c and diabetes-knowledge scores in the telemedicine group, but the participants had type 1 diabetes, not type 2. Both the telemedicine and face-to-face groups improved, so the study does not establish that a particular virtual-care component caused the gains. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. The effect of intensive treatment of diabetes on the de- velopment of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
  2. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in pa- tients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
  3. Klonoff DC, True MW: The missing element of tele- medicine for diabetes: decision support software. J Dia- betes Sci Technol 2009;3:996-1001.
  4. Bellazzi R: Telemedicine and diabetes management: cur- rent challenges and future research directions. J Diabetes Sci Technol 2008;2:98-104.
  5. Trief PM, Izquierdo R, Eimicke JP, Teresi JA, Goland R, Palmas W, Shea S, Weinstock RS: Adherence to diabetes self care for white, African-American and Hispanic Ameri- can telemedicine participants: 5 year results from the IDEATel project. Ethn Health 2013;1:83-96.
  6. Klonoff DC: Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, pa- tient education, and telemedicine support. J Diabetes Sci Technol 2012;6:486-490.
  7. Davis RM, Hitch AD, Salaam MM, Herman WH, Zimmer- Galler IE, Mayer-Davis EJ: TeleHealth improves diabetes self-management in an underserved community: diabetes telecare. Diabetes Care 2010;33:1712-1717.
  8. Rossi MC, Nicolucci A, Di Bartolo P, Bruttomesso D, Girelli A, Ampudia FJ, Kerr D, Ceriello A, Mayor Cde L, Pellegrini F, Horwitz D, Vespasiani G: Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open- label, international, multicenter, randomized study. Dia- betes Care 2010;33:109-115.
  9. Siriwardena LS, Wickramasinghe WA, Perera KL, Mar- asinghe RB, Katulanda P, Hewapathirana R: A review of telemedicine interventions in diabetes care. J Telemed Telecare 2012;18:164-168.
  10. Franc S, Daoudi A, Mounier S, Boucherie B, Dardari D, Laroye H, Neraud B, Requeda E, Canipel L, Charpentier G: Telemedicine and diabetes: achievements and prospects. Diabetes Metab 2011;37:463-476.
  11. Farmer A, Gibson OJ, Tarassenko L, Neil A: A systematic review of telemedicine interventions to support blood glu- cose self-monitoring in diabetes. Diabet Med 2005;22: 1372-1378.
  12. Marrero DG, Vandagriff JL, Kronz K, Fineberg NS, Golden MP, Gray D, Orr DP, Wright JC, Johnson NB: Using telecommunication technology to manage children with diabetes: the Computer-Linked Outpatient Clinic (CLOC) Study. Diabetes Educ 1995;21:313-319.
  13. Nunn E, King B, Smart C, Anderson D: A randomized controlled trial of telephone calls to young patients with poorly controlled type 1 diabetes. Pediatr Diabetes 2006;7: 254-259.
  14. Chase HP, Pearson JA, Wightman C, Roberts MD, Oder- berg AD, Garg SK: Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care 2003;26:1475-1479.
  15. Jansa `M, Vidal M, Viaplana J, Levy I, Conget I, Gomis R, Esmatjes E: Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control. Diabetes Res Clin Pract 2006; 74:26-32.
  16. Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, Catargi B, Melki V, Chaillous L, Farret A, Bosson JL, Penfornis A; TeleDiab Study Group: The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine sup- port improves HbA 1C in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel- group, multicenter trial (TeleDiab 1 Study). Diabetes Care 2011;34:533-539.
  17. Moreno L, Dale SB, Chen AY, Magee CA: Costs to Medicare of the Informatics for Diabetes Education and Telemedicine (IDEATel) home telemedicine demonstra- tion. Diabetes Care 2009;32:1202-1204.
  18. Influence of intensive diabetes treatment on quality-of-life outcomes in the Diabetes Control and Complications Trial. Diabetes Care 1996;19:195-203.
  19. Millan M, Reviriego J, Del Campo J: Reappraisal of the Spanish version of the Diabetes Quality of Life Ques- tionaire (EsDQOL). Endocrinol Nutr 2002;49:322-324.
  20. Lennon GM, Taylor KG, Debney L: Knowledge, attitudes, technical competence and blood glucose control of type 1 diabetic patients during and after an education programme. Diabet Med 1990;7:825-832.
  21. Jansa `M, Vidal M, Gime ´nez M, Conget I, Galindo M, Roca D, Colungo C, Esmatjes E, Salamero M: Psychometric analysis of the Spanish and Catalan versions of the Dia- betes Self-Care Inventory-revised version questionnaire. Patient Prefer Adherence 2013;7:997-1005.
  22. Weinger K, Butler HA, Welch GW, La Greca AM: A psychometric analysis of the Self-Care Inventory-revised with adults. Diabetes Care 2005;28:1346-1352.
  23. Altman DG, Bland JM: Parametric v non-parametric methods for data analysis. BMJ 2009;338:a3167.
  24. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W: Reduced awareness of hypogly- cemia in adults with IDDM. A prospective study of hypo- glycemic frequency and associated symptoms. Diabetes Care 1995;18:517-522.
  25. Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC: Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care 2004;27: 1088-1094.
  26. Levin K, Madsen JR, Petersen I, Wanscher CE, Hangaard J: Telemedicine diabetes consultations are cost-effective, and effects on essential diabetes treatment parameters are similar to conventional treatment: 7-year results from the Svendborg Telemedicine Diabetes Project. J Diabetes Sci Technol 2013;7:587-595.

Cited by

Sorted by citations

Authors
Esmatjes, E., Jansà, M., Roca, D., Pérez-Ferre, N., del Valle, L., Martínez-Hervás, S., Ruiz de Adana, M., Linares, F., Batanero, R., Vázquez, F., Gomis, R., de Solà-Morales, O., & for the Telemed-Diabetes Group
Affiliations
  • Hospital Clínic de Barcelona (ES)
  • University of Barcelona
  • San Carlos Hospital Clinic
  • University of Valencia
  • Carlos Haya University Hospital
  • Cruces University Hospital
  • University of the Basque Country (ES)
  • Health Institute Technology Transfer
Corresponding author
Esmatjes, Enric
Venue
Diabetes Technology & Therapeutics
Published
2014-07
Volume
16
Issue
7
Pages
435-441
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W185917258
Cited by
64
References
0
Citations by year
2025: 4 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 6 · 2015: 5 · 2014: 3
FWCI
6.94
Type
journal article
Language
en
Open access
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (acceptedVersion)
Funders
Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 1 diabetes, telemedicine, glycemic control, HbA1c, health care costs, patient time, diabetes knowledge, self-care adherence, quality of life, remote patient monitoring
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Health Knowledge, Attitudes, Practice, Male, Patient Education as Topic, Prospective Studies, Quality of Life, Self Care, Spain, Program Evaluation, Telemedicine, Internet, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review